August 31, 2026
US FDA Approval of MIMRYLO™(rusfertide) for Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)
calendar_today
August 31, 2026
domain
protagonist-therapeutics
Need help?
Contact usAugust 31, 2026